Daan Gene Co., Ltd.
SHZ: 002030.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yang Wang
- Employees
- 1,968
- Headquarters
- Guangzhou, China
- IPO year
- 2004
- Market cap
- CN¥9.3B
- Website
- https://www.daangene.com
Loading 002030…
Loading profile data…Frequently asked questions about 002030
What does Daan Gene Co., Ltd. (002030.SZ) do?
Daan Gene Co., Ltd. researches and develops, manufactures, and sells clinical test reagents and instruments. The company offers fluorescence quantitative PCR products, time resolution series products, enzyme-linked immunoassay products, instrument products, and scientific research service products. It also provides medical examination, and healt...
Where does 002030.SZ trade?
Daan Gene Co., Ltd. (002030.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002030.SZ in?
Daan Gene Co., Ltd. (002030.SZ) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Daan Gene Co., Ltd.?
Yang Wang is the chief executive officer of Daan Gene Co., Ltd. (002030.SZ).
Where is Daan Gene Co., Ltd. headquartered?
Daan Gene Co., Ltd. is headquartered in China.
Does 002030.SZ pay a dividend?
Yes — Daan Gene Co., Ltd. (002030.SZ) paid a trailing twelve-month dividend of CNY 0.02 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 002030.SZ go public?
Daan Gene Co., Ltd. (002030.SZ) completed its initial public offering in 2004.